Perea-Bartolome et al. BMC Public Health 2011, 11:504 http://www.biomedcentral.com/1471-2458/11/504 38. Yaffe K: Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord 2007, 21(2):167-171. 39. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi YA, Laakso M, Kuusisto J: Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006, 67(5):843-847. 40. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW: Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007, 30(10):2655-2660. 41. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383. 42. Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47(11):1245-1251. 43. Solomon PR, Murphy CA: Should we screen for Alzheimer’s disease? A review of the evidence for and against screening Alzheimer’s disease in primary care practice. Geriatrics 2005, 60(11):26-31. 44. Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, Paffenbarger RS Jr: Physical activity assessment methodology in the Five- City Project. Am J Epidemiol 1985, 121(1):91-106. 45. Mahoney FI, Barthel DW: Functional Evaluation: The Barthel Index. Md State Med J 1965, 14:61-65. 46. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9(3):179-186. 47. Jorm AF: A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 1994, 24(1):145-153. 48. Jorm AF: The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr 2004, 16(3):275-293. 49. Folstein MF, Folstein SE, McHugh PR: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189-198. 50. Solomon PR, Hirschoff A, Kelly B, Relin M, Brush M, DeVeaux RD, Pendlebury WW: A 7 minute neurocognitive screening battery highly sensitive to Alzheimer’s disease. Arch Neurol 1998, 55(3):349-355. 51. del Ser Quijano T, Sanchez Sanchez F, Garcia de Yebenes MJ, Otero Puime A, Zunzunegui MV, Munoz DG: [Spanish version of the 7 Minute screening neurocognitive battery. Normative data of an elderly population sample over 70]. Neurologia 2004, 19(7):344-358. 52. González-Montalvo JI: Creación y validación de un test de lectura para el diagnóstico del deterioro mental en el anciano. Universidad Complutense de Madrid; 1991. 53. Wechsler D: Wechsler Memory Scale - Revised manual San Antonio, TX: Psychological Corporation; 1987. 54. Kaplan E, Goodglass H, Weintraub S: Test de vocabulario de Boston. In Evaluación de la afasia y trastornos relacionados.. Second edition. Edited by: Goodglass H, Kaplan E. Madrid: Panamericana; 1986:. 55. Goodglass H, Kaplan E: Evaluación de la afasia y de trastornos relacionados Madrid: Panamericana; 1986. 56. Babcock H: An experiment in the measurement of mental deterioration. Archieves of Psychology 1930, 117:105. 57. Rey A: Test de copia de la figura compleja Madrid: TEA; 1987. 58. Benton AL: TRVB. Test de Retención Visual de Benton Madrid: TEA; 1981. 59. Dubois B, Slachevsky A, Litvan I, Pillon B: The FAB: a Frontal Assessment Battery at bedside. Neurology 2000, 55(11):1621-1626. 60. Piatt AL, Fields JA, Paolo AM, Troster AI: Action (verb naming) fluency as an executive function measure: convergent and divergent evidence of validity. Neuropsychologia 1999, 37(13):1499-1503. 61. Reisberg B, Ferris SH, de Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982, 139(9):1136-1139. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2458/11/504/prepub doi:10.1186/1471-2458-11-504 Cite this article as: Perea-Bartolome et al.: Detection of mild cognitive impairment in people older than 65 years of age and its relationship to cardiovascular risk factors (DECRIVAM). BMC Public Health 2011 11:504. Page 8 of 8 Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit